Atrial fibrillation and the use of oral bisphosphonates

Pazianas, M., Cooper, C., Wang, Y. et al. (2 more authors) (2011) Atrial fibrillation and the use of oral bisphosphonates. Therapeutics and Clinical Risk Management, 7. pp. 131-144. ISSN 1176-6336

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2011 Pazianas et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. https://creativecommons.org/licenses/by-nc/3.0/
Keywords: atrial fibrillation; chemically induced osteoporosis; drug therapy; alendronate or risedronate; bisphosphonates; adverse effects
Dates:
  • Published (online): 22 March 2011
  • Published: 22 March 2011
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Human Metabolism (Sheffield)
The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 25 Nov 2019 16:20
Last Modified: 26 Nov 2019 08:08
Status: Published
Publisher: Dove Medical Press Ltd.
Refereed: Yes
Identification Number: https://doi.org/10.2147/tcrm.s17899
Related URLs:

Export

Statistics